How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    • Has all of the relevant evidence been taken into account?

  • Question on Consultation

    Are the summaries of clinical and resource savings reasonable interpretations of the evidence?

  • Question on Consultation

    • Are the recommendations sound and a suitable basis for guidance to the NHS?

  • Question on Consultation

    Are there any equality issues that need special consideration and are not covered in the medical technology consultation document?
The content on this page is not current guidance and is only for the purposes of the consultation process.

Pulmonary artery pressure technologies for remote monitoring of chronic heart failure

Closed for comments This consultation ended on at   Request commenting lead permission

Guidance development process

NICE diagnostics guidance evaluates diagnostic tests and technologies. It provides evidence-based recommendations about how accurate and effective the tests are, as well as their costs. The guidance supports healthcare professionals and commissioners to choose the best diagnostic options to improve patient care. NICE aims to enhance the quality of diagnostic practices in the UK, leading to better health outcomes for patients.

Find out more on the NICE webpage on the diagnostics assessment programme.

NICE is producing this guidance on pulmonary artery pressure technologies for remote monitoring of chronic heart failure in the NHS in England. The diagnostics advisory committee has considered the evidence and the views of clinical and patient experts.

This document has been prepared for consultation with the stakeholders. It summarises the evidence and views that have been considered, and sets out the recommendations made by the committee. NICE invites comments from the stakeholders for this evaluation and the public. This document should be read along with the evidence.

The committee is interested in receiving comments on the following:

  • Has all of the relevant evidence been taken into account?

  • Are the summaries of clinical and cost effectiveness reasonable interpretations of the evidence?

  • Are the recommendations sound and a suitable basis for guidance to the NHS?

  • Are there any aspects of the recommendations that need particular consideration to ensure we avoid unlawful discrimination against any group of people on the grounds of age, disability, gender reassignment, pregnancy and maternity, race, religion or belief, sex or sexual orientation?

After consultation:

  • Based on the consultation comments received, the committee may meet again.

  • If committee meets again, it will consider the evidence, this evaluation consultation document and comments from stakeholders.

  • The committee will then prepare the final draft guidance, which will go through a resolution process before the final guidance is agreed.

Note that this document is not NICE's final guidance on pulmonary artery pressure technologies for remote monitoring of chronic heart failure. The recommendations in section 1 may change after consultation.

More details are available in NICE's health technology evaluations: the manual.

Key dates:

Closing date for comments: 11 November 2025

Second committee meeting: 18 November 2025